Dermatologybimekizumabplaque psoriasis
Bimekizumab Sustains Complete Skin Clearance and Quality of Life Improvements Through Three Years in Plaque Psoriasis: Insights from the BE RADIANT Trial
By MedXY|Feb 19, 2026
The BE RADIANT trial demonstrates that bimekizumab provides rapid, superior, and durable skin clearance (PASI 100) and symptom relief compared to secukinumab over three years, with a manageable safety profile and significant quality-of-life
